EBTi and BGI Health Ethiopia PLC sign MoU in HPV Genotyping Pilot Project
Addis Ababa– The Ethiopian Biotechnology Institute (EBTi) and BGI Health Ethiopia PLC signed a memorandum of understanding (MoU) in HPV Genotyping Pilot Project and technological relations.
The MoU intends to collaborate to carry out the HPV genotyping pilot project and complete 2000 sample screenings collected from Ethiopia in the responsibility of the EBTi in close collaboration with the HPV consortium and then which will be Genotyped by BGI. After finding this HPV pilot project, both sides will establish a new model, including HPV screening, diagnosis, and treatment in Ethiopia. According to the MOU signed, in line with the completion of the Pilot Project BGI and EBTi will continue their collaboration for large-scale HPV screening tests and then establish a genomic center in Ethiopia, enhancing the national genomics testing capacity.
According to the agreement, the two parties will organize events to bring together experts and stakeholders for the implementation procedure and awareness-raising programs.
BGI Health Ethiopia PLC is one of the world’s leading test and research service Providers and also as a federal entity, EBTi has a national mandate to organize, lead and coordinate biotechnology and emerging technology researches and development across the country through partnerships with national and international institutions.
Dr. Hailu Dadi, Deputy Director-General of EBTi, and Mr. Chen Songheng, BGI Health Ethiopia, signed the MoU, April 27th, 2021.